A detailed history of Black Rock Inc. transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,827,577 shares of NAUT stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,827,577
Previous 3,731,804 2.57%
Holding current value
$10.1 Million
Previous $11 Million 18.37%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.22 - $3.0 $212,616 - $287,319
95,773 Added 2.57%
3,827,577 $8.96 Million
Q1 2024

May 10, 2024

SELL
$2.41 - $3.18 $390,017 - $514,628
-161,833 Reduced 4.16%
3,731,804 $11 Million
Q4 2023

Feb 13, 2024

BUY
$2.34 - $3.39 $362,203 - $524,731
154,788 Added 4.14%
3,893,637 $11.6 Million
Q3 2023

Nov 13, 2023

BUY
$2.87 - $3.94 $386,086 - $530,028
134,525 Added 3.73%
3,738,849 $11.8 Million
Q2 2023

Aug 11, 2023

BUY
$2.21 - $4.52 $669,470 - $1.37 Million
302,928 Added 9.18%
3,604,324 $13.9 Million
Q1 2023

May 12, 2023

SELL
$1.67 - $2.77 $75,028 - $124,447
-44,927 Reduced 1.34%
3,301,396 $9.14 Million
Q4 2022

Feb 13, 2023

BUY
$1.55 - $2.47 $212,084 - $337,967
136,829 Added 4.26%
3,346,323 $6.02 Million
Q3 2022

Nov 14, 2022

SELL
$1.96 - $3.13 $91,214 - $145,663
-46,538 Reduced 1.43%
3,209,494 $6.8 Million
Q2 2022

Aug 12, 2022

BUY
$2.64 - $4.84 $5.41 Million - $9.92 Million
2,050,046 Added 169.99%
3,256,032 $8.76 Million
Q1 2022

May 12, 2022

SELL
$3.5 - $5.3 $160,517 - $243,068
-45,862 Reduced 3.66%
1,205,986 $5.23 Million
Q4 2021

Feb 10, 2022

BUY
$4.45 - $6.21 $104,842 - $146,307
23,560 Added 1.92%
1,251,848 $6.49 Million
Q3 2021

Nov 09, 2021

BUY
$6.14 - $10.1 $1.42 Million - $2.34 Million
231,491 Added 23.22%
1,228,288 $7.54 Million
Q2 2021

Aug 11, 2021

BUY
$9.04 - $14.19 $9.01 Million - $14.1 Million
996,797 New
996,797 $10.1 Million

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $330M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.